EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Influence of Preexisting Psychiatric Morbidity on Liothyronine Use in Hypothyroidism: A Swedish Nationwide Cohort Study

Fredric Hedberg iD, Jonatan D Lindh iD, Buster Mannheimer iD, Tereza Planck iD, Jakob Skov, Mikael Lehtihet, Henrik Falhammar iD, Jan Calissendorff

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgaf337 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Fredric Hedberg und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital L1:00, Stockholm SE-171 76, Sweden. Hauptthemen laut MEDLINE: Mental Disorders, Triiodothyronine, Thyroiditis, Autoimmune, Hashimoto Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region Stockholm Drug and Therapeutic Committee, the Lisa and Johan Grönberg Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Autoimmune hypothyroidism is a common endocrine disorder affecting 1% to 2% of the population in iodine sufficient areas. While levothyroxine is standard treatment, a substantial number of patients report persistent symptoms despite adequate treatment. The use of liothyronine as an adjunct to levothyroxine therapy has increased. The psychiatric characteristics of patients receiving liothyronine remain largely unknown.

Objective

This study examines the association between preexisting psychiatric morbidity and subsequent liothyronine use in autoimmune hypothyroidism.

Methods

This nationwide retrospective cohort study includes all adults in Sweden with autoimmune hypothyroidism and initiated on treatment with thyroid hormones between 2006 and 2020. Data were obtained from the National Patient Register and the National Prescribed Drug Register. Psychiatric morbidity prior to diagnosis was identified using ICD-10 codes and ATC codes for psychiatric medications. Logistic models estimated associations, adjusting for sex, age, and region.

Results

Among 353 708 patients, 44.8% had a history of psychiatric morbidity. These patients were more likely to receive liothyronine (adjusted odds ratio [aOR] 1.90, 95% CI 1.83-1.97, P < .001) than those without a psychiatric history. This was most evident among individuals with affective or anxiety morbidity (aOR 1.91, 95% CI 1.84-1.98, P < .001). No association was found for psychotic morbidity (aOR 1.08, 95% CI 0.98-1.19, P = .11).

Conclusion

Patients with a psychiatric history before autoimmune hypothyroidism were more likely to receive liothyronine, especially among those with affective or anxiety morbidity. This may reflect persistent symptoms and affect subsequent decisions in the treatment of hypothyroidism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mental DisordersTriiodothyronineThyroiditis, AutoimmuneHashimoto DiseaseHypothyroidismHumansFemaleMaleSwedenMiddle AgedRetrospective StudiesAgedAdultThyroxineHormone Replacement TherapyRegistriesFollow-Up Studies

Stichwörter der Autor:innen

LT3autoimmune hypothyroidismcombination therapyepidemiologypsychiatric morbidity

Substanzen

TriiodothyronineThyroxine

Autor:innen und Institutionen

  • Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital L1:00, Stockholm SE-171 76, Sweden.
  • Department of Endocrinology, Karolinska University Hospital, Stockholm 17176, Sweden.
  • Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Stockholm 14152, Sweden.
  • Department of Clinical Science and Education at Södersjukhuset, Karolinska Institutet, Stockholm 11883, Sweden.
  • Department of Internal Medicine, Section Diabetes and Endocrinology, Södersjukhuset, Stockholm 11883, Sweden.
  • Department of Endocrinology, Skåne University Hospital, Malmö 21428, Sweden.

ORCID-Profile: Fredric Hedberg, Jonatan D Lindh, Buster Mannheimer, Tereza Planck, Henrik Falhammar

Förderung

  • Region Stockholm Drug and Therapeutic Committee
  • the Lisa and Johan Grönberg Foundation

Zitieren

APA

Hedberg, F., Lindh, J. D., Mannheimer, B., Planck, T., Skov, J., Lehtihet, M., Falhammar, H., & Calissendorff, J. (2025). Influence of Preexisting Psychiatric Morbidity on Liothyronine Use in Hypothyroidism: A Swedish Nationwide Cohort Study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf337

Vancouver

Hedberg F, Lindh JD, Mannheimer B, Planck T, Skov J, Lehtihet M, et al. Influence of Preexisting Psychiatric Morbidity on Liothyronine Use in Hypothyroidism: A Swedish Nationwide Cohort Study. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf337

BibTeX
@article{Hedberg2025,
  author = {Hedberg, Fredric and Lindh, Jonatan D and Mannheimer, Buster and Planck, Tereza and Skov, Jakob and Lehtihet, Mikael and Falhammar, Henrik and Calissendorff, Jan},
  title = {Influence of Preexisting Psychiatric Morbidity on Liothyronine Use in Hypothyroidism: A Swedish Nationwide Cohort Study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgaf337}
}
Kostenlos starten →